Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessEconomy

DBS revises India's GDP estimate to 1.5% for FY21

The Singaporean lender said it sees the lockdown/ restrictive movements will be eased in phases by end-Q2.

April 09, 2020 / 07:58 PM IST
Representative Image

Representative Image

Singapore's banking group DBS on Thursday revised the country's GDP estimate to 1.5 percent for the current fiscal amid the current lockdown due to COVID-19. This comes a day after American brokerage Goldman Sachs revised its forecast for the country's real GDP growth to 1.6 percent as against 3.3 percent it had estimated earlier.

"We have revised GDP estimate for FY21 at 1.5 percent year-on year vs 4.5 percent in FY20," DBS Bank India's economist Radhika Rao said in a report.

Weakening global growth outlook will also impinge on the country's trajectory.

The Singaporean lender said it sees the lockdown/ restrictive movements will be eased in phases by end-Q2.

It said on average every month contributes to around eight percent of the full-year output and a month's closure amounts to close to four percent of output loss.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"If we assume that manufacturing, mining, services except those in the public domain are at nil capacity and lockdown extends, potential output loss rises to 5-6 percent of GDP," Rao said.

The report said that from the demand-side, about 75 percent of the economy is below trend, hurting consumption and investment activity.

It also said a third of personal final consumption expenditure is discretionary, items like spending on recreation, restaurants, travel etc.

"Movement restrictions are likely to adversely impact consumption and employment prospects of these categories," it said.

The report further said The Centre and state borrowings may jump, with deficits likely to be 200-300 basis points higher than the baseline.

Follow our full coverage of the coronavirus pandemic here.

PTI
first published: Apr 9, 2020 07:43 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347